Peripheral XXXX associated with gastrointestinal administration of iodinated contrast media.

@entity1 @entity1712 @entity4946 @entity1372 @entity1503 @entity3989
OBJECTIVE: This study was designed to assess whether gastrointestinal administration of iodinated contrast media results in peripheral @entity1503 . MATERIALS AND METHODS: We studied 110 @entity1 in a retrospective review. @entity3989 and @entity4946 for abdominal CT were administered to 98 of these @entity1 ; 22 of the 98 had also been given the same contrast medium administered by enema. The remaining 12 @entity1 were given diatrizoate @entity1372 for gastrointestinal fluoroscopy. A control group of 65 @entity1 underwent single-contrast barium upper gastrointestinal or enema examinations. WBC and eosinophil counts were determined approximately 24 hr before the examination and every 24 hr thereafter, through the ninth day. RESULTS: @entity1712 was detected in 17 (15.5%) of 110 @entity1 after gastrointestinal administration of iodinated contrast media. The prevalence of @entity1712 after administration of iodinated contrast media was statistically significantly different compared with that in the control group, in which none of the 65 @entity1 had @entity1712 (p < 0.001). @entity1712 was detected 48 hr after application of iodinated contrast agents and lasted through the sixth day, with a peak on the fifth day. The prevalence of @entity1712 was independent of route of application, dose, or type of iodinated contrast medium. @entity1712 in all cases was clinically asymptomatic. CONCLUSION: @entity1712 that is caused by gastrointestinal administration of iodinated contrast media is a transient, clinically silent phenomenon. It may lead to unnecessary workup for known conditions associated with @entity1712 .
